Glucagon-like peptide-1 receptor agonists, aka GLP-1 drugs, were originally approved and used for treatment of Type 2 diabetes, with the first product debuting in 2005
This is also the period where non-responders become apparent
As a busy professional focused on your career and personal life, we know your time is precious
In animal models, glucagon stimulates energy expenditure through activation of brown adipose tissue [68], although the significance of this effect has not been confirmed by human data [69]
Rajiv Singhal, president general secretary, All India Organisation of Chemists and Druggists (AIOCD), says tirzepatides lead in the market has been driven by its superior efficacy in both glycemic control and weight reduction
Kassem K.M., Vaid S., Peng H., Sarkar S., Rhaleb N.E